TERT and breast carcinoma: Among them, three are mostly described: C228T and C250T hotspot mutations of TERT promoter, promoter rearrangements, gains of copy numbers and focal amplifications of TERT. However, in breast cancer, limited literature is available on TERT alterations and mainly at locally advanced settings.